Log in
Enquire now
Arthrogen B.V.

Arthrogen B.V.

Arthrogen B.V. was acquired by MeiraGTx, a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases.

OverviewStructured DataIssuesContributors

MeiraGTx is a clinical-stage gene therapy company with six programs in clinical development including four ocular indications, a salivary gland condition, and a Parkinson’s disease program.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Arthrogen B.V.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.